285 related articles for article (PubMed ID: 19484742)
41. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
Moleirinho S; Chang N; Sims AH; Tilston-Lünel AM; Angus L; Steele A; Boswell V; Barnett SC; Ormandy C; Faratian D; Gunn-Moore FJ; Reynolds PA
Oncogene; 2013 Apr; 32(14):1821-30. PubMed ID: 22614006
[TBL] [Abstract][Full Text] [Related]
42. The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.
Shanzer M; Ricardo-Lax I; Keshet R; Reuven N; Shaul Y
Oncogene; 2015 Aug; 34(32):4190-8. PubMed ID: 25362852
[TBL] [Abstract][Full Text] [Related]
43. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP.
Huang J; Wu S; Barrera J; Matthews K; Pan D
Cell; 2005 Aug; 122(3):421-34. PubMed ID: 16096061
[TBL] [Abstract][Full Text] [Related]
44. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
[TBL] [Abstract][Full Text] [Related]
45. Hippo signaling in the kidney: the good and the bad.
Wong JS; Meliambro K; Ray J; Campbell KN
Am J Physiol Renal Physiol; 2016 Aug; 311(2):F241-8. PubMed ID: 27194720
[TBL] [Abstract][Full Text] [Related]
46. The Hippo pathway member Nf2 is required for inner cell mass specification.
Cockburn K; Biechele S; Garner J; Rossant J
Curr Biol; 2013 Jul; 23(13):1195-201. PubMed ID: 23791728
[TBL] [Abstract][Full Text] [Related]
47. MOB1 Mediated Phospho-recognition in the Core Mammalian Hippo Pathway.
Couzens AL; Xiong S; Knight JDR; Mao DY; Guettler S; Picaud S; Kurinov I; Filippakopoulos P; Sicheri F; Gingras AC
Mol Cell Proteomics; 2017 Jun; 16(6):1098-1110. PubMed ID: 28373298
[TBL] [Abstract][Full Text] [Related]
48. Snapshots of a hybrid transcription factor in the Hippo pathway.
Luo X
Protein Cell; 2010 Sep; 1(9):811-9. PubMed ID: 21203923
[TBL] [Abstract][Full Text] [Related]
49. MOB control: reviewing a conserved family of kinase regulators.
Hergovich A
Cell Signal; 2011 Sep; 23(9):1433-40. PubMed ID: 21539912
[TBL] [Abstract][Full Text] [Related]
50. Tension-dependent regulation of mammalian Hippo signaling through LIMD1.
Ibar C; Kirichenko E; Keepers B; Enners E; Fleisch K; Irvine KD
J Cell Sci; 2018 Mar; 131(5):. PubMed ID: 29440237
[TBL] [Abstract][Full Text] [Related]
51. The regulation and function of YAP transcription co-activator.
Zhu C; Li L; Zhao B
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920
[TBL] [Abstract][Full Text] [Related]
52. The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway.
Silva E; Tsatskis Y; Gardano L; Tapon N; McNeill H
Curr Biol; 2006 Nov; 16(21):2081-9. PubMed ID: 16996266
[TBL] [Abstract][Full Text] [Related]
53. The Hippo Pathway Targets Rae1 to Regulate Mitosis and Organ Size and to Feed Back to Regulate Upstream Components Merlin, Hippo, and Warts.
Jahanshahi M; Hsiao K; Jenny A; Pfleger CM
PLoS Genet; 2016 Aug; 12(8):e1006198. PubMed ID: 27494403
[TBL] [Abstract][Full Text] [Related]
54. A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription.
Bao Y; Nakagawa K; Yang Z; Ikeda M; Withanage K; Ishigami-Yuasa M; Okuno Y; Hata S; Nishina H; Hata Y
J Biochem; 2011 Aug; 150(2):199-208. PubMed ID: 21586534
[TBL] [Abstract][Full Text] [Related]
55.
Kim E; Kang JG; Kang MJ; Park JH; Kim YJ; Kweon TH; Lee HW; Jho EH; Lee YH; Kim SI; Yi EC; Park HW; Yang WH; Cho JW
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14259-14269. PubMed ID: 32513743
[TBL] [Abstract][Full Text] [Related]
56. Differential requirement of Salvador-Warts-Hippo pathway members for organ size control in Drosophila melanogaster.
Milton CC; Zhang X; Albanese NO; Harvey KF
Development; 2010 Mar; 137(5):735-43. PubMed ID: 20110315
[TBL] [Abstract][Full Text] [Related]
57. [Role of the Hippo pathway in cell proliferation and organ size control. Disorders of the pathway in cancer diseases].
Rybarczyk A; Wierzbicki P; Kowalczyk A; Kmieć Z
Postepy Hig Med Dosw (Online); 2014 May; 68():503-15. PubMed ID: 24864102
[TBL] [Abstract][Full Text] [Related]
58. YAP and TAZ in epithelial stem cells: A sensor for cell polarity, mechanical forces and tissue damage.
Elbediwy A; Vincent-Mistiaen ZI; Thompson BJ
Bioessays; 2016 Jul; 38(7):644-53. PubMed ID: 27173018
[TBL] [Abstract][Full Text] [Related]
59. The NDR/LATS protein kinases in neurobiology: Key regulators of cell proliferation, differentiation and migration in the ocular and central nervous system.
Santos PF; Fazendeiro B; Luca FC; Ambrósio AF; Léger H
Eur J Cell Biol; 2023 Jun; 102(2):151333. PubMed ID: 37327741
[TBL] [Abstract][Full Text] [Related]
60. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
